[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 209, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew Craig Kapusta CPA", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1127977, "exercisedValue": 32490, "unexercisedValue": 2761994}, {"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 679793, "exercisedValue": 0, "unexercisedValue": 282015}, {"maxAge": 1, "name": "Dr. Jeannette  Potts J.D., Ph.D.", "age": 62, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 738547, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walid  Abi-Saab M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 946132, "exercisedValue": 0, "unexercisedValue": 268795}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Porter Ph.D.", "age": 56, "title": "Chief Business & Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 732169, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Chiara Elizabeth Russo", "title": "Senior Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamara  Tugal Ph.D., MBA", "title": "Business Development Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Boyer", "title": "Chief People & Culture Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 4, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 23.93, "open": 23.72, "dayLow": 23.1, "dayHigh": 25.4, "regularMarketPreviousClose": 23.93, "regularMarketOpen": 23.72, "regularMarketDayLow": 23.1, "regularMarketDayHigh": 25.4, "payoutRatio": 0.0, "beta": 0.588, "forwardPE": -7.6947384, "volume": 6661299, "regularMarketVolume": 6661299, "averageVolume": 4989151, "averageVolume10days": 3743720, "averageDailyVolume10Day": 3743720, "bid": 18.34, "ask": 22.81, "bidSize": 2, "askSize": 1, "marketCap": 1494376960, "fiftyTwoWeekLow": 7.76, "fiftyTwoWeekHigh": 71.5, "allTimeHigh": 82.49, "allTimeLow": 3.73, "priceToSalesTrailing12Months": 94.87505, "fiftyDayAverage": 37.9863, "twoHundredDayAverage": 22.60155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1331794048, "profitMargins": 0.0, "floatShares": 45909579, "sharesOutstanding": 62291663, "sharesShort": 8335603, "sharesShortPriorMonth": 6901368, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.1338, "heldPercentInsiders": 0.053260002, "heldPercentInstitutions": 0.91693, "shortRatio": 1.94, "shortPercentOfFloat": 0.1354, "impliedSharesOutstanding": 62291663, "bookValue": 3.68, "priceToBook": 6.5190215, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -235146000, "trailingEps": -4.4, "forwardEps": -3.117715, "enterpriseToRevenue": 84.553, "enterpriseToEbitda": -8.628, "52WeekChange": 0.37636256, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 23.99, "targetHighPrice": 96.135185, "targetLowPrice": 33.27788, "targetMeanPrice": 55.307404, "targetMedianPrice": 54.507965, "recommendationMean": 1.41667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 694244992, "totalCashPerShare": 11.145, "ebitda": -154366000, "totalDebt": 531662016, "quickRatio": 6.937, "currentRatio": 7.117, "totalRevenue": 15751000, "debtToEquity": 232.425, "revenuePerShare": 0.291, "returnOnAssets": -0.13893, "returnOnEquity": -1.65266, "grossProfits": -123151000, "freeCashflow": -75263000, "operatingCashflow": -153238000, "revenueGrowth": 0.618, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -13.29722, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "corporateActions": [], "postMarketTime": 1766191806, "regularMarketTime": 1766178001, "exchange": "NMS", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.250729, "regularMarketPrice": 23.99, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "postMarketChangePercent": 0.75031394, "postMarketPrice": 24.17, "postMarketChange": 0.1800003, "regularMarketChange": 0.0599995, "regularMarketDayRange": "23.1 - 25.4", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4989151, "fiftyTwoWeekLowChange": 16.23, "fiftyTwoWeekLowChangePercent": 2.0914948, "fiftyTwoWeekRange": "7.76 - 71.5", "fiftyTwoWeekHighChange": -47.510002, "fiftyTwoWeekHighChangePercent": -0.66447556, "fiftyTwoWeekChangePercent": 37.636257, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1753792200, "earningsCallTimestampEnd": 1753792200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.4, "epsForward": -3.117715, "epsCurrentYear": -3.3502, "priceEpsCurrentYear": -7.1607666, "fiftyDayAverageChange": -13.996302, "fiftyDayAverageChangePercent": -0.36845654, "twoHundredDayAverageChange": 1.3884506, "twoHundredDayAverageChangePercent": 0.061431658, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]